SignatureFD’s Korro Bio KRRO Stock Holding History

SignatureFD’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-41	Closed	-$1.56K	–	3383
2024 Q4	$1.56K	Hold	41	–	–	﹤0.01%	2935
2024 Q3	$1.37K	Buy	+41	New	+$1.73K	﹤0.01%	2931

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SignatureFD's KRRO Position: Q1 2025 in Review

SignatureFD sold out of Korro Bio (KRRO) in Q1 2025, closing a stake of 41 shares — an estimated $1.56K sold.

SignatureFD first reported a position in KRRO in Q3 2024 and held it in 2 quarters. The position peaked at $1.56K in Q4 2024. 75 funds tracked by Wall St. Rank hold KRRO as of Q1 2025.

SignatureFD reported no remaining Korro Bio position as of Q1 2025 after selling out during the quarter.
SignatureFD sold 41 Korro Bio shares in Q1 2025, an estimated $1.56K.
SignatureFD first reported a position in Korro Bio in Q3 2024 and held it in 2 quarters.
SignatureFD's Korro Bio position peaked at $1.56K in Q4 2024.
75 funds tracked by Wall St. Rank held Korro Bio as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.